BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 23616572)

  • 1. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.
    Oishi H; Tsubaki T; Miyazaki T; Ono M; Nose M; Takahashi S
    J Immunol; 2013 Mar; 190(5):2129-37. PubMed ID: 23365086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
    Saito K; Mori S; Date F; Ono M
    Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice.
    Booker JK; Reap EA; Cohen PL
    J Immunol; 1998 Nov; 161(9):4536-41. PubMed ID: 9794379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
    Ratkay LG; Tait B; Tonzetich J; Waterfield JD
    J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic dissection of vasculitis in MRL/lpr lupus mice: a novel susceptibility locus involving the CD72c allele.
    Qu WM; Miyazaki T; Terada M; Lu LM; Nishihara M; Yamada A; Mori S; Nakamura Y; Ogasawara H; Yazawa C; Nakatsuru S; Nose M
    Eur J Immunol; 2000 Jul; 30(7):2027-37. PubMed ID: 10940892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
    Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
    J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of T-cell receptor beta-chain variable region genes in lymph nodes of lpr mice with different alleles of the major histocompatibility complex.
    Ohga S; Yoshikai Y; Kishihara K; Matsuzaki G; Ogimoto M; Nomoto K
    Immunology; 1990 Jun; 70(2):216-22. PubMed ID: 2373519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
    Nijnik A; Ferry H; Lewis G; Rapsomaniki E; Leung JC; Daser A; Lambe T; Goodnow CC; Cornall RJ
    Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
    Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M
    Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci.
    Nose M; Nishihara M; Kamogawa J; Terada M; Nakatsuru S
    Rev Immunogenet; 2000; 2(1):154-64. PubMed ID: 11324688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of B and T lymphocyte attenuator exacerbates autoimmune disorders and induces Fas-independent liver injury in MRL-lpr/lpr mice.
    Oya Y; Watanabe N; Kobayashi Y; Owada T; Oki M; Ikeda K; Suto A; Kagami S; Hirose K; Kishimoto T; Nakajima H
    Int Immunol; 2011 May; 23(5):335-44. PubMed ID: 21521881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.